Literature DB >> 21184813

Hippocampal synaptic metaplasticity requires the activation of NR2B-containing NMDA receptors.

Qian Yang1, Zhen-Hua Liao, Yi-Xin Xiao, Qing-Shu Lin, Yi-Sheng Zhu, Sheng-Tian Li.   

Abstract

The potential to exhibit synaptic plasticity itself is modulated by previous synaptic activity, which has been termed as metaplasticity. In this paper, we demonstrated that the activation of N-methyl-d-aspartate (NMDA) receptor 2B (NR2B) subunit in NNDA receptors was required for hippocampal metaplasticity at Schaffer collateral-commissural fiber-CA1 synapses. Brief 5 Hz priming stimulation did not cause long-term synaptic plasticity; however, it could result in the inhibition of subsequently evoked long-term potentiation (LTP). Meanwhile, the application of selective antagonists for NR2B subunit of NMDA receptors after delivering priming stimulation could block the metaplasticity. In contrast, LTP induction was not affected by NR2B antagonists in slices without pre-treatment of priming stimulation. These results indicated that the activation of NR2B-containing NMDA receptors was required for metaplasticity.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184813     DOI: 10.1016/j.brainresbull.2010.12.009

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

Review 1.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

Review 2.  Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications.

Authors:  Chen-Chen Jiang; Li-Shan Lin; Sen Long; Xiao-Yan Ke; Kohji Fukunaga; Ying-Mei Lu; Feng Han
Journal:  Signal Transduct Target Ther       Date:  2022-07-11

3.  CaMKII Metaplasticity Drives Aβ Oligomer-Mediated Synaptotoxicity.

Authors:  Patricio Opazo; Silvia Viana da Silva; Mario Carta; Christelle Breillat; Steven J Coultrap; Dolors Grillo-Bosch; Matthieu Sainlos; Françoise Coussen; K Ulrich Bayer; Christophe Mulle; Daniel Choquet
Journal:  Cell Rep       Date:  2018-06-12       Impact factor: 9.423

4.  GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Authors:  Jeffrey Burgdorf; Xiao-lei Zhang; Katherine L Nicholson; Robert L Balster; J David Leander; Patric K Stanton; Amanda L Gross; Roger A Kroes; Joseph R Moskal
Journal:  Neuropsychopharmacology       Date:  2012-12-05       Impact factor: 7.853

5.  Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase.

Authors:  Norelle C Wildburger; Fernanda Laezza
Journal:  Front Mol Neurosci       Date:  2012-07-16       Impact factor: 5.639

6.  PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.

Authors:  Yang Lu; Chuang Wang; Zhancheng Xue; Chenli Li; Junfang Zhang; Xin Zhao; Aiming Liu; Qinwen Wang; Wenhua Zhou
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-25       Impact factor: 5.176

7.  FRET-FLIM investigation of PSD95-NMDA receptor interaction in dendritic spines; control by calpain, CaMKII and Src family kinase.

Authors:  Kim Doré; Simon Labrecque; Christian Tardif; Paul De Koninck
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 8.  Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity.

Authors:  Sung-Soo Jang; Hee Jung Chung
Journal:  Neural Plast       Date:  2016-02-25       Impact factor: 3.599

Review 9.  Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).

Authors:  Andrei-Nicolae Vasilescu; Nina Schweinfurth; Stefan Borgwardt; Peter Gass; Undine E Lang; Dragos Inta; Sarah Eckart
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-31       Impact factor: 2.570

10.  Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro.

Authors:  Yuan Yuan; Zhe Sun; Yi Chen; Yuxin Zheng; Ke-Liang Xie; Ying He; Zhifen Wang; Guo-Lin Wang; Yong-Hao Yu
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.